Skip to main content
Technology

The FDA wants to pull its approval of a drug. It’s not so easy.

The FDA wants to pull its approval of a drug. It’s not so easy.

Feed excerpt — reported by Ars Technica

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Ars Technica →

Original Source

This article was syndicated from Ars Technica. All rights remain with the original publisher.